13F-HR filed by Healthcare Value Capital, LLC
Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-07, with 13 holding rows worth $35,275,000.
- Accession
- 0000919574-18-005179
- Filer
- CIK 1458461
- Filed
- 2018-08-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 13 entries on the cover page, a total value of $35,275,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $35,275,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 100,000 | $7,084,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| TYME TECHNOLOGIES INC COM | 90238J103 | Stock | 2,075,000 | $6,557,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 1,313,387 | $4,833,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 100,000 | $4,031,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ALLERGAN PLC | G0177J108 | SHS | 20,000 | $3,334,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| PROSHARES TR ULTSH NASD BIOT | 74347B789 | CEF | 150,000 | $2,921,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 450,000 | $2,682,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 500,000 | $1,545,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 150,000 | $1,424,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 100,000 | $309,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
| ANTARES PHARMA INC | 036642106 | COM | 100,000 | $258,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ANTARES PHARMA INC | 036642106 | COM | 100,000 | $258,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
| APRICUS BIOSCIENCES INC | 03832V307 | COM NEW | 100,000 | $39,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-18-005179 | this filing | 2018-08-07 | acceptance time not in the bulk data set |